These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8055574)

  • 1. Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization.
    Tommaso CL
    Cathet Cardiovasc Diagn; 1994 Apr; 31(4):316-21. PubMed ID: 8055574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-media induced nephropathy in patients undergoing coronary angiography.
    Gomes VO; Blaya P; Poli de Figueiredo CE; Manfroi W; Caramori P
    J Invasive Cardiol; 2003 Jun; 15(6):304-10. PubMed ID: 12777666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-induced nephropathy.
    Marenzi G; Cabiati A; Milazzo V; Rubino M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S181-3. PubMed ID: 23073854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.
    Chawla R; Turlington J; Arora P; Jovin IS
    Int J Cardiol; 2017 Mar; 230():610-613. PubMed ID: 28040287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
    Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
    Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast-induced nephropathy after cardiac catheterization: a prospective study of 180 patients].
    Mghaieth F; Ayari J; Ben Rejeb R; Mbarki S; Farhati A; Larbi N; Boussaada R; Mourali MS; Mechmeche R
    Tunis Med; 2012 Apr; 90(4):320-7. PubMed ID: 22535348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
    Sato A; Aonuma K; Watanabe M; Hirayama A; Tamaki N; Tsutsui H; Toyoaki M; Ogawa H; Akasaka T; Yoshimura M; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K; Saito Y;
    Int J Cardiol; 2017 Jan; 227():424-429. PubMed ID: 27838134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Zhao SJ; Zhong ZS; Qi GX; Tian W
    Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contrast-induced nephropathy: An update].
    Spagnoli V; Azzalini L; Tadros VX; Picard F; Ly HQ
    Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):87-94. PubMed ID: 26926776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SICI-GISE/SIN Consensus document: Contrast-induced acute kidney injury in interventional cardiology].
    Ronco F; Azzalini L; Briguori C; Cosmai L; D'Amico M; Di Luca M; Esposito G; Granatelli A; Maddestra N; De Marco F; La Manna A; Maioli M; Musumeci G; Tarantino F; Venturelli C; Brunori G; Tarantini G
    G Ital Cardiol (Rome); 2019 Sep; 20(9 Suppl 1):29S-43S. PubMed ID: 31593189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
    Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of acetylcysteine in the prevention of contrast-media-induced nephrotoxicity.
    Raven QL; Walton T; Howe AM; Macon EJ
    Am J Health Syst Pharm; 2003 Nov; 60(21):2232-5. PubMed ID: 14619114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.